Brief: Corline Biomedical Q4 operating loss widens to SEK 2.2 mln
Feb 24 (Reuters) - Corline Biomedical AB CLBIO.ST :
* Q4 net sales 150,000 Swedish crowns ($17,636) versus 677,000 crowns year ago
* Q4 operating loss 2.2 million crowns versus loss 0.6 million crowns year ago
Source text for Eikon: ID:nHUG5SQNDT
Further company coverage: CLBIO.ST
($1 = 8.5051 Swedish crowns)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))
Recent news on Corline Biomedical AB
See all newsBrief: Corline Biomedical Expectes Positive EBITDA In 2027
Brief: Corline Biomedical: Canada To Grant Kardium Up To C$31.25 Mln For Manufacturing Capacity Expansion
Brief: Corline Biomedical Q2 Net Sales Amount To SEK 4.7 Million
Brief: Corline Biomedical Partner Kardium Receives Approval For Globe Pulsed Field System In Canada
Brief: Corline Biomedical Q1 Result After Financial Items At SEK -2.5 Mln